The prevalence of Klebsiella pneumoniae in surgical site infections (SSIs) has increased recently. This study aimed to evaluate the antimicrobial resistance patterns and biofilm formation capacity of K. pneumoniae strains isolated from SSIs.
Methods:
A total of 63 K. pneumoniae isolates were obtained from patients with SSIs. Antimicrobial susceptibility testing was determined using the Kirby–Bauer method. Molecular analyses were performed to confirm the presence of virulence and antibiotic resistance genes. Biofilm formation was determined using a semiquantified microtiter plate assay, and optical density measurements were used to classify the isolates into weak, moderate, and strong biofilm producers. Biofilm structure was observed using field-emission scanning electron microscopy. Statistical analyses were performed using SPSS software version 16 (SPSS Inc., Chicago, IL, USA), and data were analyzed and presented in terms of frequency and percentage.
Results:
The frequencies of fimH, mrkD, mrkA, wcaG, and magA were 98.4%, 96.8%, 77.7%, 61.9%, and 7.9%, respectively. The highest rates of antibiotic resistance were observed for cefazolin, cefuroxime, and piperacillin/tazobactam and 98.4% of the isolates were resistant to at least one antibiotic agent. The most prevalent resistance genes were blaSHV (42.8%), blaCTX-M (31.7%), blaTEM (28.5%), and blaOXA48 (22.2%). All the tested isolates were able to produce biofilms, and 76.2% were classified as strong biofilm producers.
Conclusions:
Klebsiella pneumoniae is one of the common pathogens in SSIs, and due to its antibiotic resistance and the presence of multiple virulence factors, proper controlling strategies need to be carried out.
Get full access to this article
View all access options for this article.
References
1.
Chung TheH, KarkeyA, Pham ThanhD, et al.A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of Klebsiella pneumoniae. EMBO Mol Med, 2015; 7(3):227–239; doi: 10.15252/emmm.201404767
2.
VuottoC, LongoF, PascoliniC, et al.Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. J Appl Microbiol, 2017; 123(4):1003–1018; doi: 10.1111/jam.13533
3.
De RosaFG, CorcioneS, CavalloR, et al.Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda. Future Microbiol, 2015; 10(2):283–294; doi: 10.2217/fmb.14.121
4.
SinghaiM, MalikA, ShahidM, et al.A study on device-related infections with special reference to biofilm production and antibiotic resistance. J Glob Infect Dis, 2012; 4(4):193–198; doi: 10.4103/0974-777X.103896
5.
BandeiraM, Almeida CarvalhoP, DuarteA, et al.Expolring dangerous connections between Klebsiella pneumoniae biofilms and healthcare-associated infections. Pathogens, 2014; 3(3):720–731; doi: 10.3390/pathogens3030720
6.
ChungPY. The emerging problems of Klebsiella pneumoniae infections: Carbapenem resistance and biofilm formation. FEMS Microbiol Lett, 2016; 363(20):fnw219; doi: 10.1093/femsle/fnw219
7.
ShiC, SunY, ZhengZ, et al.Antimicrobial activity of syringic acid against Cronobacter sakazakii and its effect on cell membrane. Food Chem, 2016; 197(Pt A):100–106; doi: 10.1016/j.foodchem.2015.10.100
8.
Alcántar-CurielMD, BlackburnD, SaldañaZ, et al.Multi-functional analysis of Klebsiella pneumoniae fimbrial types in adherence and biofilm formation. Virulence, 2013; 4(2):129–138; doi: 10.4161/viru.22974
9.
WasfiR, ElkhatibWF, AshourHM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep, 2016; 6:38929; doi: 10.1038/srep38929
10.
ZhengJ, LinZ, ChenC, et al.Biofilm formation in Klebsiella pneumoniae bacteremia strains was found to be associated with CC23 and the presence of wcaG. Front Cell Infect Microbiol, 2018; 8:21.
11.
FerreiraRL, da SilvaBCM, RezendeGS, et al.High prevalence of multidrug-resistant Klebsiella pneumoniae harboring several virulence and β-lactamase encoding genes in a Brazilian intensive care unit. Front Microbiol, 2018; 9:3198; doi: 10.3389/fmicb.2018.03198
12.
CompainF, BabosanA, BrisseS, et al.Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J Clin Microbiol, 2014; 52(12):4377–4380; doi: 10.1128/JCM.02316-14
13.
CleggS, MurphyCN. Epidemiology and virulence of Klebsiella pneumoniae. Microbiol Spectr, 2016; 4(1); doi: 10.1128/microbiolspec.UTI-0005-2012
14.
RobatjaziS, NikkhahiF, NiazadehM, et al.Phenotypic identification and genotypic characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Iran. Curr Microbiol, 2021; 78(6):2317–2323; doi: 10.1007/s00284-021-02479-9
15.
PatersonDL, MulazimogluL, CasellasJM, et al.Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis, 2000; 30(3):473–478; doi: 10.1086/313719
16.
NikkhahiF, RobatjaziS, NiazadehM, et al.First detection of mobilized colistin resistance mcr-1 gene in Escherichia coli isolated from livestock and sewage in Iran. New Microbes New Infect, 2021; 41:100862; doi: 10.1016/j.nmni.2021.100862
17.
RojekSW, WojtowiczI, TacconeFS, et al.Colistin use for the treatment of multi-drug-resistant Gram-negative severe infections in ICU patients: A single-center study. J Clin Med, 2025; 14(3):797; doi: 10.3390/jcm14030797
18.
RhoumaM, BeaudryF, ThériaultW, et al.Colistin in pig production: Chemistry, mechanism of antibacterial action, microbial resistance emergence, and one health perspectives. Front Microbiol, 2016; 7:1789; doi: 10.3389/fmicb.2016.01789
PodschunR, UllmannU. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev, 1998; 11(4):589–603.
21.
DiancourtL, PassetV, VerhoefJ, et al.Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol, 2005; 43(8):4178–4182; doi: 10.1128/JCM.43.8.4178-4182.2005
22.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, Melvin P. Weinstein, informational supplement M100–S31. 31st ed. CSLI; 2021.
23.
AmerehS, KelishomiFZ, GhayazF, et al.Activity of meropenem-vaborbactam against different beta-lactamase producing Klebsiella pneumoniae and Escherichia coli isolates in Iran. Acta Microbiol Immunol Hung, 2022; 69(3):201–208; doi: 10.1556/030.2022.01782
24.
RebeloAR, BortolaiaV, KjeldgaardJS, et al.Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Euro Surveill, 2018; 23(6); doi: 10.2807/1560-7917.ES.2018.23.6.17-00672
25.
BorowiakM, FischerJ, HammerlJA, et al.Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother, 2017; 72(12):3317–3324; doi: 10.1093/jac/dkx327
26.
AbuOunM, StubberfieldEJ, DuggettNA, et al.mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Antimicrob Chemother, 2017; 72(10):2745–2749; doi: 10.1093/jac/dkx286
27.
KumabeA, KenzakaT. String test of hypervirulent Klebsiella pneumonia. QJM, 2014; 107(12):1053; doi: 10.1093/qjmed/hcu124
28.
AnariRK, NikkhahiF, JavadiA, et al.Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran. BMC Microbiol, 2022; 22(1):257; doi: 10.1186/s12866-022-02664-1
29.
YasudaH, AjikiY, KogaT, et al.Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother, 1994; 38(1):138–141; doi: 10.1128/AAC.38.1.138
30.
HaghighifarE, Kamali DolatabadiR, Dept. of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Bacterial infections and antimicrobial resistance patterns of burn wound infections: A one-year study from burn hospital, Isfahan, Iran. J Adv Med Biomed Res, 2020; 28(128):144–150; doi: 10.30699/jambs.28.128.144
31.
NouriF, KamareheiF, AsghariB, et al.Prevalence and drug resistance patterns of bacteria isolated from wound and blood stream nosocomial infections in Hamadan, West of Iran. Life, 2022; 15(1):174–182; doi: 10.1080/26895293.2022.2032384
32.
MasoudSS, KovacevichA, GangjiR, et al.Extent and resistance patterns of ESKAPE pathogens isolated in pus swabs from hospitalized patients. Can J Infect Dis Med Microbiol, 2022; 2022:3511306–3511307; doi: 10.1155/2022/3511306
33.
PerweenN, PrakashSK, SiddiquiO. Multi drug resistant Klebsiella isolates in burn patients: A comparative study. J Clin Diagn Res, 2015; 9(9):DC14–DC16; doi: 10.7860/JCDR/2015/13837.6576
34.
SeifiK, KazemianH, HeidariH, et al.Evaluation of biofilm formation among Klebsiella pneumoniae isolates and molecular characterization by ERIC-PCR. Jundishapur J Microbiol, 2016; 9(1):e30682; doi: 10.5812/jjm.30682
35.
ShadkamS, GoliHR, MirzaeiB, et al.Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran. Ann Clin Microbiol Antimicrob, 2021; 20(1):13; doi: 10.1186/s12941-021-00418-x
36.
LeeH-C, ChuangY-C, YuW-L, et al.Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: Association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med, 2006; 259(6):606–614; doi: 10.1111/j.1365-2796.2006.01641.x
37.
ChuangY, FangC, LaiS, et al.Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis, 2006; 193(5):645–654; doi: 10.1086/499968
38.
SoltaniE, HasaniA, RezaeeMA, et al.An alliance of carbapenem-resistant Klebsiella pneumoniae with precise capsular serotypes and clinical determinants: A disquietude in hospital setting. Can J Infect Dis Med Microbiol, 2022; 2022:6086979–6086979; doi: 10.1155/2022/6086979
39.
PeiranoG, PitoutJD, LauplandKB, et al.Population-based surveillance for hypermucoviscosity Klebsiella pneumoniae causing community-acquired bacteremia in Calgary, Alberta. Can J Infect Dis Med Microbiol, 2013; 24(3):e61–e64; doi: 10.1155/2013/828741
40.
KarimiK, ZareiO, SedighiP, et al.Investigation of antibiotic resistance and biofilm formation in clinical isolates of Klebsiella pneumoniae. Int J Microbiol, 2021; 2021:5573388; doi: 10.1155/2021/5573388
41.
Cruz-CórdovaA, Esteban-KenelV, Espinosa-MazariegoK, et al.Pathogenic determinants of clinical Klebsiella pneumoniae strains associated with their persistence in the hospital environment. Bol Méd Hosp Infant México, 2014; 71(1):15–24.
42.
KhoshnoodS, AkramiS, SakiM, et al.Molecular evaluation of aminoglycosides resistance and biofilm formation in Klebsiella pneumoniae clinical isolates: A cross‐sectional study. Health Sci Rep, 2023; 6(5):e1266; doi: 10.1002/hsr2.1266
43.
MirzaieA, RanjbarR. Antibiotic resistance, virulence-associated genes analysis and molecular typing of Klebsiella pneumoniae strains recovered from clinical samples. AMB Express, 2021; 11(1):122; doi: 10.1186/s13568-021-01282-w
44.
Saadatian FarivarA, NowrooziJ, EslamiG, et al.RAPD PCR profile, antibiotic resistance, prevalence of armA gene, and detection of KPC enzyme in Klebsiella pneumoniae isolates. Can J Infect Dis Med Microbiol, 2018; 2018:6183162–6183167; doi: 10.1155/2018/6183162
45.
DalfinoL, PuntilloF, MoscaA, et al.High-dose, extended-interval colistin administration in critically ill patients: Is this the right dosing strategy? A preliminary study. Clin Infect Dis, 2012; 54(12):1720–1726; doi: 10.1093/cid/cis286
46.
NiazadehM, NikkhahiF, RobatjaziS, et al.Evaluation of mechanisms of colistin resistance in Klebsiella pneumoniae strains isolated from patients with urinary tract infection in ICU. Iran J Microbiol, 2022; 14(1):31–37; doi: 10.18502/ijm.v14i1.8798
47.
SinghaiM, KumarA, JhaP, et al.Bacteriological and resistance profile in isolates from diabetic patients. N Am J Med Sci, 2012; 4(11):563–568; doi: 10.4103/1947-2714.103315
48.
GaoF, XiongZ, LiangB, et al.Molecular characterization and epidemiology of carbapenem-resistant Enterobacteriaceae isolated from pediatric patients in Guangzhou, Southern China. Can J Infect Dis Med Microbiol, 2023; 2023:4762143–4762148; doi: 10.1155/2023/4762143
